Figures & data
Figure 1 Daily mean doses of background AEDs in the study population.
Abbreviations: AED, antiepileptic drug; CBZ, carbamazepine; LEV, levetiracetam; LMT, lamotrigine; OXC, oxcarbazepine; PHT, phenytoin; TPM, topiramate; VA, valproic acid; ZNS, zonisamide.
![Figure 1 Daily mean doses of background AEDs in the study population.](/cms/asset/00e0eb72-a8b1-4a84-94b3-af91ba2d9085/dtcr_a_171793_f0001_b.jpg)
Table 1 Demographic characteristics of the patients
Table 2 Etiologic classification of the patient population
Table 3 Comparison of patients with and without IDD
Figure 2 Kaplan–Meier survival analysis showed that the retention rates were significantly lower in patients with IDD when compared to those in patients without IDD (P=0.04).
![Figure 2 Kaplan–Meier survival analysis showed that the retention rates were significantly lower in patients with IDD when compared to those in patients without IDD (P=0.04).](/cms/asset/c985eb44-c2c3-4f1a-8c01-440e37348c58/dtcr_a_171793_f0002_c.jpg)
Table 4 Retention rates of LCM treatment during follow-up in patients with and without IDD
Table 5 Daily dosage scheme of LCM and other AEDs at the time of discontinuation and the reasons for discontinuing LCM are shown
Table 6 Cox regression analysis showed that use of traditional sodium channel blockers was the only independent predictor of retention rate of LCM treatment
Table 7 Proposed criteria for forced normalization